Obagi Medical Products presents promising in vitro data for topical C serums

July 31, 2008

Chicago - Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com.

Chicago

- Obagi Medical Products announces

in vitro

data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, according to Marketwatch.com.

In addition, the Obagi Professional-C Serum had a five-fold greater absorption of vitamin C than the leading competitive product, and both Obagi products were proven to have a greater stability than the leading competitor.